Cullinan Therapeutics Inc (CGEM)

Investing Cash Flow

$40.68M

Quarterly · Period ending: · USD

CGEM logo

CGEM Investing Cash Flow

Latest reported$40.68M
CGEM Quarterly Cash from Investing (-$5.50K → $40.68M)
High-resolution chart · PNG

CGEM investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cullinan Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
40,678,000
32,414,000
22,391,000
67,392,000
53,401,000
36,805,000
15,964,000
19,878,000
-185,112,000
12,956,000
51,470,000
-42,958,000
12,110,000
15,184,000
-28,610,000
-57,978,000
300,852,000
34,711,000
-15,862,000
-25,593,000
-154,594,000
-137,726,000
11,440,000
-1,941,000
11,971,000
-26,890,000
-35,385,000
-4,000
-5,500
-5,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.